[ad_1]
Japan Health The Department of Labor and Welfare (MHLW) has approved a blood test that can detect signs of Alzheimer’s disease.
The diagnostic kit, produced by the Kobe-based company Sysmex, can measure the “amyloid beta” protein in the brains of Alzheimer’s patients.
Test The kit will provide early diagnosis and treatment by measuring the amount of “amyloid beta” protein in a small amount of blood taken from the patient.
Known as an abnormal protein that causes congestion in nerve cells in the brain, “amyloid beta” is known as a symptom of Alzheimer’s disease.
“We are preparing for both the rapid launch of the product and its inclusion under Japanese national health insurance,” Sysmex said in a statement. it was said.
[ad_2]
Source link
